Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate

By sjmartinez • August 29, 2023

Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU; Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. J Clin Oncol. 2023 Aug 28:JCO2300617. doi: 10.1200/JCO.23.00617. Epub ahead of print. PMID: 37639648.

Tags: General Internal Medicine, Publications

Melanoma in situ and low risk pT1a melanoma: Need for new diagnostic terminology

Elder DE, Barnhill RL, Eguchi M, Elmore JG, Kerr KF, Knezevich S. Melanoma in situ and low risk pT1a melanoma: Need for new diagnostic terminology.[...]

Youth Engagement Synergy in Mental Health Legislation and Programming

Kang E, Kindler C, Saint Amour AT, Locus K, Hosaka KRJ, Leslie MC, Patel NA. Youth Engagement Synergy in Mental Health Legislation and Programming. Child[...]

MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics

Kathuria-Prakash N, Dave P, Garcia L, Brown P, Drakaki A. MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics. Int J Mol[...]